Sensipar Cinacalcet Tablets Recalled Due to CGMP Deviations
Amgen, Inc. is recalling Sensipar (cinacalcet) 60 mg tablets nationwide due to Current Good Manufacturing Practice (CGMP) deviations. The recall affects 30-count bottles with Lot #1157055 and expiration date 1/31/2028.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The FDA classified this as Class II. The source does not report any hospitalization, deaths, serious injuries, or confirmed adverse health consequences. CGMP deviations represent a potential manufacturing control issue without demonstrated patient harm, placing this within the Moderate category.
Plain-English summary
Amgen, Inc. is recalling Sensipar (cinacalcet hydrochloride) 60 mg tablets distributed nationwide in the United States. The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations identified during manufacturing. The affected product is distributed in 30-count bottles, NDC 55513-074-30, with Lot #1157055 and expiration date 1/31/2028.
This is a Class II recall initiated voluntarily by the firm. Patients taking this medication should not stop taking their prescription without consulting their healthcare provider. Patients who have this lot should contact their pharmacy or healthcare provider for guidance on obtaining an unaffected supply or alternative treatment.
The recalled product
- Product
- SENSIPAR (CINACALCET HYDROCHLORIDE)
- Brand
- SENSIPAR
- Manufacturer
- Amgen, Inc.
- Category
- Drug — Prescription Tablet
- Hazard
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 1157055
- Exp. Date 1/31/2028
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · SENSIPAR
- ModerateSensipar cinacalcet hydrochloride tablets recalled for CGMP deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar (Cinacalcet Hydrochloride) Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-01
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateSensipar cinacalcet hydrochloride tablets recalled for CGMP deviations
FDA (Drugs) · 2026-07-01
- HighLacosamide 100mg Tablets Recalled Due to Foreign Tablet Contamination
FDA (Drugs) · 2026-07-01
- ModerateCorlanor Ivabradine Tablets Recalled for Foreign Substance Contamination
FDA (Drugs) · 2026-07-01
- ModerateCorlanor ivabradine tablets recalled for presence of foreign substance
FDA (Drugs) · 2026-07-01